Document is current
Any future updates will be listed below
-
Authors
Belayew, Alexandra
Rosa, Alberto L.
Zammit, Peter S.
-
Funding
Funding for this research was provided by:
Argentina National Research Council (N/A)
Medical Research Council (MR/X001520/1)
- License Information
-
More Information
Article History
Received: 14 April 2025
Accepted: 20 June 2025
First Online: 25 August 2025
Declarations
:
: Not applicable.
: Not applicable.
: Alexandra Belayew is co-inventor on a patent “Agents useful in treating FSHD” owned by the University of Mons and licensed to Dyne Therapeutics. The other authors declare no competing interests.
